Anixa Biosciences announced that its CEO Dr. Amit Kumar and a breast cancer vaccine trial patient will be featured on Bloomberg TV to discuss recent successes in their breast cancer vaccine development. The vaccine aims to treat, prevent recurrence, and potentially reduce the risk of developing breast cancer. The company collaborates with leading institutions like Cleveland Clinic and Moffitt Cancer Center to develop innovative cancer immunotherapies and vaccines. This media exposure could boost investor awareness as Anixa advances its clinical-stage cancer treatments.
Palantir's stock rose about 28.8% from July to now, driven by a 93% year-over-year revenue increase to $1.94 billion in Q2 2026 and strong profitability. The company expanded its AI offerings through new partnerships with Nebius and PwC, alongside de...
Hybrid Power Solutions Inc. has established a larger manufacturing facility in Mississauga, Ontario, to increase production capacity for its fuel-free and hybrid portable power products. The new facility will feature dedicated production lines for th...
Nvidia's top insider, Director Mark Stevens, sold nearly $650 million worth of shares in two transactions, including the largest insider sale of the decade for Nvidia. This insider selling is part of a broader trend among big tech companies like Micr...
Graphene Manufacturing Group (GMG) announced that its G®CELLS graphene batteries have demonstrated exceptional durability, showing no performance loss after 489 cycles of fast charging and discharging within six minutes each. This performance signifi...
Pump.fun and Kraken removed their promotional posts for the upcoming $LAPTOP memecoin linked to Hunter Biden following strong negative reactions from traders. The token is planned to launch on the Base blockchain platform. This move highlights the se...
